cnbc.com
🌐 65% Global Worthiness
HIMS Stock Rises Despite Volatility, Driven by Diverse Revenue Streams
Hims & Hers Health (HIMS) stock price rose from $23.50 in July to $32.50 currently, despite September's dip below $14; its compounded semaglutide injections, representing under 10% of revenue, contribute to volatility, while the company shows continued strength.
HIMS Stock Rises Despite Volatility, Driven by Diverse Revenue Streams
Hims & Hers Health (HIMS) stock price rose from $23.50 in July to $32.50 currently, despite September's dip below $14; its compounded semaglutide injections, representing under 10% of revenue, contribute to volatility, while the company shows continued strength.
Progress
40% Bias Score
Good Health and Well-being